Healthy Skepticism Library item: 10361

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Foley P.
Osteoporosis & Menopausal Disorders-SMi Conference.
IDrugs 2003 Jul; 6:(7):660-3

Abstract:

In what proved to be a varied and interesting conference, many issues relating to osteoporosis and menopausal disorders were discussed, including existing therapies, safety, public perception, commercialization and predictions for the future. During his closing remarks, Professor Genazzani noted that the increase in aging core populations in many countries means that these areas are likely to continue to gain prominence. The area of osteoporosis was neglected until recently, although health authorities and drug developers are now realizing the extent of the problem. Professor Genazzani noted that, in addition, there remains a need for improved public education regarding exercise, diet and calcium intake.

Keywords:
Cathepsins/antagonists & inhibitors Clinical Trials Estrogen Replacement Therapy Female Humans Isoflavones/therapeutic use Osteoporosis, Postmenopausal/drug therapy* Osteoporosis, Postmenopausal/prevention & control* Peptide Fragments/therapeutic use Phytoestrogens Plant Preparations/therapeutic use Receptors, Calcium-Sensing/antagonists & inhibitors Vitamin D/analogs & derivatives Vitamin D/therapeutic use